Several mortality-risk prediction models used in assessing mortality at 1-year in patients with idiopathic pulmonary fibrosis may also be a viable option in gauging short-term mortality in patients with systemic sclerosis-associated interstitial lung disease, according to study results.

Researchers studied 156 patients with SSc-ILD and used four baseline risk prediction models normally used to assess mortality in patients with IPF. The researchers utilized the CPI, the ILD-GAP Index, the du Bois index and the modified du Bois index to estimate 1-year mortality rates in SSc-ILD.

Each index accurately predicted patient 1-year mortality, with the modified du Bois index showing the best discrimination.